Navigation Links
Amgen Resolves G-CSF Patent Litigation With Teva
Date:7/15/2011

THOUSAND OAKS, Calif., July 15, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced today that the United States (U.S.) District Court in Pennsylvania has entered final judgment and a permanent injunction against Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA prohibiting them from infringing Amgen's patents relating to human G-CSF (granulocyte colony-stimulating factor) and methods for its use. Today's judgment was accompanied by Teva's admission that its Neutroval™ product infringes the two Amgen patents at issue in the litigation and that those patents are valid and enforceable.  The Court's injunction extends until Nov. 10, 2013, after which date Teva may sell Neutroval in the U.S.  Regarding Neugranin™, another Teva G-CSF product, Teva agrees not to sell Neugranin until Nov. 10, 2013 unless it first obtains a final court decision that Amgen's patents are not infringed by Neugranin. Pursuant to the parties' agreement, the launch date for either product could be sooner if certain unexpected events occur: a third party launches a similar G-CSF product and Amgen fails to sue that third party, or the patents are held invalid or unenforceable in a final court decision in an action brought by a third party. The settlement terms do not include any financial payments between the parties. The two patents at issue in the litigation, U.S. Patent Nos. 5,580,755 and 5,582,823, expire in early December 2013.

"We are very pleased with this outcome, as it reaffirms the validity of these important patents," said David J. Scott, senior vice president, general counsel and secretary at Amgen. "This closes this matter and allows Amgen to continue to focus on bringing innovative therapies to patients with grievous illnesses."

About Amgen

Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnol
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss
2. Amgen Announces Modifications to U.S. Prescribing Information for Use of Erythropoiesis-Stimulating Agents in Chronic Kidney Disease
3. Teachers and Schools Across North America Receive $10,000 Amgen Award for Science Teaching Excellence
4. Amgen Announces Voting Results Of Annual Meeting of Stockholders
5. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
6. Amgen Oncology Data to be Presented at ASCO Annual Meeting
7. Amgen to Webcast Investor Meeting at Upcoming American Urological Association Conference
8. Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California
9. Amgen to Present at the Deutsche Bank 36th Annual Healthcare Conference
10. Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans
11. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Ambit Biosciences Corporation (Nasdaq: ... clinical investigations of quizartinib (AC220), a potent and selective ... of the American Society of Clinical Oncology, held May ... Chicago . Information ... listed below. Abstracts can be viewed online at ...
(Date:5/22/2013)... 22, 2013 /PRNewswire-iReach/ -- MarketReportsOnline.com announces addition of ... Series (4) 2013 Edition Material and Clinical Trial ... Registration: A Guidebook of Registration Application for Imported ... its online database. The traditional medicines ... always regarded by occidental as mysterious medicines. Until ...
(Date:5/22/2013)... May 22, 2013 Assured Pharmacy, Inc. (APHY), ... medications to sufferers of chronic pain, announced it has ... investor relations firm, to raise its visibility and strengthen ... the past year, we have proven our business model ... plans to open two additional new pharmacies in ...
Breaking Medicine Technology:Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology 2Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 2China Pharmaceutical Market Guidebook Series (4) 2013 Report 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 4China Pharmaceutical Market Guidebook Series (4) 2013 Report 5Assured Pharmacy Hires Hayden IR 2Assured Pharmacy Hires Hayden IR 3
... Dec. 13, 2010 Out of hundreds ... Medicare DualChoice (HMO SNP) is one of only five plans across ... quality and performance from the Centers for Medicare and Medicaid Services ... how well health and drug plans perform on a scale of ...
... 13, 2010 Montefiore Medical Center has introduced a ... reflux disease (GERD), most commonly known as acid reflux. ... not require any incisions, recovery is faster and it ... next step in the evolution of surgery, which can ...
Cached Medicine Technology:IEHP Earns Highest Rating for Medicare Part D Quality and Performance 2Natural Orifice Surgery Introduced to Relieve Acid Reflux 2Natural Orifice Surgery Introduced to Relieve Acid Reflux 3
(Date:5/22/2013)... Garcinia cambogia select is a dual action fat burner ... fat being stored in the body. For a rapid weight ... burner helps people in this regard by making the consumer ... does this by secreting a hormone serotonin which makes people ... emotional overeating. In this way, it keeps a control on ...
(Date:5/22/2013)... Los Angeles, CA (PRWEB) May 22, 2013 ... board, The J. M. Smucker Company, and Danny ... Awards yesterday at the GS1 General Assembly and Global ... Mr. Smucker and Mr. Wegman were recognized for their ... Standards - the most broadly used supply chain standards ...
(Date:5/22/2013)... and teens exposed to radiation during CT scans are ... a large, long-term study. The risks, however, are ... who each had one CT scan, only about six ... years, according to researchers from Australia and Europe. ... to patients when making decisions about CT (computed tomography) ...
(Date:5/22/2013)... German . ... establishing 11 new Research Training Groups to further support ... by the relevant Grants Committee in Bonn. Funding of ... new programmes for an initial period of four and ... Research Training Groups, the Grants Committee approved the extension ...
(Date:5/22/2013)... encouraging a baby to finish the last ounce in their ... the calories soon burn off, a bad habit remains. , ... found that clinical obesity at 24 months of age strongly ... at age two, it puts you on a trajectory where ... adolescence and as an adult," said Forste. "That,s a big ...
Breaking Medicine News(10 mins):Health News:Garcinia Cambogia Reviews Released Online for Fast Weight Loss Solution with Offer of Extra 3 Month Supply 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 3Health News:Children Who Have CT Scans May Face Higher Cancer Risk 2Health News:DFG establishes 11 new research training groups 2Health News:DFG establishes 11 new research training groups 3Health News:DFG establishes 11 new research training groups 4Health News:DFG establishes 11 new research training groups 5Health News:Overeating learned in infancy, study suggests 2
... difference in effectiveness of 5 drugs currently available , , ... that any one of the five drugs available in ... the others, says an American College of Physicians (ACP) ... just issued a new guideline on drug treatment of ...
... Publishing, an award-winning interactive, visual content developer, today ... the first free, Web-based 3-D interactive model of ... educators, and health and medical professionals, The Visible ... how the human body works. It will also ...
... ANNAPOLIS, Md., March 4 Dozens of ... gathered in Annapolis today as,the General Assembly ... regulations, protections against identity theft, and the ... visited legislators,offices and attended committee hearings on ...
... Market Segments, CHICAGO, March 4 Throw ... Financial services firms, insurers, and,healthcare payors admit they ... to serve baby boomers, who will control some ... who make up the wealthiest generation in history, ...
... CA A nuclear receptor protein, known for controlling ... powerful anti-inflammatory effects in arteries, suppressing atherosclerosis in mice ... research by scientists at the Salk Institute for Biological ... , Their findings, reported in this weeks online edition ...
... swayed by adolescent drug use trends , , TUESDAY, March 4 ... boys are more likely to give up the habit if ... no matter what, new research shows. , The findings ... to the wider world,s embrace of illegal drugs, said study ...
Cached Medicine News:Health News:Groups Issue New Dementia Drug Guidelines 2Health News:Argosy publishing launches The Visible Body 2Health News:Argosy publishing launches The Visible Body 3Health News:Utilities, Long Term Care Bills at Center of 'AARP Day In Annapolis' 2Health News:Diamond's Retirement Study Finds Companies Ill-Prepared to Meet Baby Boomers' Health and Wealth Needs 2Health News:Diamond's Retirement Study Finds Companies Ill-Prepared to Meet Baby Boomers' Health and Wealth Needs 3Health News:Diamond's Retirement Study Finds Companies Ill-Prepared to Meet Baby Boomers' Health and Wealth Needs 4Health News:Diamond's Retirement Study Finds Companies Ill-Prepared to Meet Baby Boomers' Health and Wealth Needs 5Health News:New potential drug target for the treatment of atherosclerosis 2Health News:New potential drug target for the treatment of atherosclerosis 3Health News:Troubled Boys Will Abandon Pot When It's Deemed Uncool 2
... care management tools that support the nursing ... vital signs and I&O information at the ... on-line flow sheets. This design supports compliance ... the hall, or at the nursing station, ...
For superior bar code scanning performance with maximum user comfort at a highly attractive price, the LS 4000i Scanner Series from Symbol Technologies establishes an award-winning standard of excell...
... thermal transfer wristband for printing quality ... that resist smears and abrasion as ... and blood. A time-tested and proven ... management applications. A tamper-evident VOID version ...
... The DataMate Laser Sheeted ... consists of laser-printable sheets ... wristband and laser labels ... The wristbands clear, fold-over ...
Medicine Products: